The Value of Everything: Making and Taking in the Global Economy

by Mariana Mazzucato

The standard defence by pharmaceutical companies used to be that these high prices are necessary to cover the R&D costs of developing new drugs and of compensating for the risks associated with both the research and the clinical trials.